Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
769.450.1%
QQQ
717.500.2%
BTC/USD
78684.740.5128%
DIA
532.880.22%
GLD
406.530.06%
TLT
82.240.04%

Chimera Investment Corp

CIMNYSE
Trade with Public
Trade with Public
$11.64
0.070.61%
At close: Sep 4, 5:00 PM EST
$11.64
N/A
After Hours: Sep 4, 5:45 PM EST
OverviewNewsEarnings ForecastPrice TargetsFinancialsSentimentOwnershipDividendsCompareOptionsStock Report

Chimera Investment Analyst Price Targets

Wall Street analyst price targets and consensus rating for Chimera Investment (CIM).

Price Target Range — 7 Quarters

Analyst Consensus — 4 Analysts

1Buy
3Hold
Consensus RatingBuy# Analysts4Avg. Consensus PT$15Upside to Avg. PT+24.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 6, 2026Keefe, Bruyette & WoodsBose GeorgePT CutMarket Perform$15→$14
Jun 3, 2026RBC CapitalKenneth S. LeeMaintainedSector Perform$14
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Keefe, Bruyette & Woods Maintains Market Perform on Chimera Investment, Lowers Price Target to $14

Keefe, Bruyette & Woods analyst Bose George maintains Chimera Investment (NYSE:CIM) with a Market Perform and lowers the price target from $15 to $14.
Benzinga Newsdesk

Wall Street's Most Accurate Analysts Weigh In On 3 Financial Stocks With Over 10% Dividend Yields

Investors seek dividend-yielding stocks during market turbulence. Benzinga provides latest analyst ratings and accurate analysts for high-yield stocks in finance.
Avi Kapoor

PRO
RBC Capital Reiterates Sector Perform on Chimera Investment, Maintains $14 Price Target

RBC Capital analyst Kenneth S. Lee reiterates Chimera Investment (NYSE:CIM) with a Sector Perform and maintains $14 price target.
Benzinga Newsdesk

Wall Street's Most Accurate Analysts Spotlight On 3 Financial Stocks Delivering High-Dividend Yields

Avi Kapoor

PRO
UBS Maintains Buy on Chimera Investment, Raises Price Target to $16

UBS analyst Douglas Harter maintains Chimera Investment (NYSE:CIM) with a Buy and raises the price target from $15 to $16.
Benzinga Newsdesk

PRO
Keefe, Bruyette & Woods Maintains Market Perform on Chimera Investment, Lowers Price Target to $15

Keefe, Bruyette & Woods analyst Bose George maintains Chimera Investment (NYSE:CIM) with a Market Perform and lowers the price target from $16.5 to $15.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved